돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 352024생성일: 2026년 10월 26일

Ammonia → HCID 10515412, 화합물

https://huagongshe.com/reaction/352024

반응식

참여 물질

역할이름HCID투입량
반응물AmmoniaHCID 222—
반응물2-NitroimidazoleHCID 10701—
반응물HexamethyldisilazaneHCID 13838—
반응물Trisodium PhosphateHCID 24243—
반응물Dibutyltin oxideHCID 61221—
반응물2-((2-Nitro-1H-imidazol-1-yl)methoxy)-1,3-propanediolHCID 129146—
반응물1,3-Propanediol, 2-((acetyloxy)methoxy)-, 1,3-diacetateHCID 9794888—
용매TolueneHCID 1140—
용매AcetonitrileHCID 6342—
생성물HCID 10515412HCID 10515412—

반응 조건

온도0 °C

반응 단계

2-Nitroimidazole was subjected to trimethylsilylation by use of hexamethyldisilazane in acetonitrile, and the resultant compound and 2-acetoxymethoxy-1,3-diacetoxypropane were subjected to condensation by use of stannic chloride serving as a catalyst. The resultant product was deprotected by use of methanolic ammonia, to thereby obtain 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole. The thus-obtained 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (0.5 g) was refluxed for two hours together with dibutyl tin oxide (0.6 g) in anhydrous toluene in the presence of molecular sieves having a pore size of 4 Å. The solvent was removed under reduced pressure, and anhydrous methylene chloride (16 mL) and anhydrous tetrahydrofuran (4 mL) were added to the residue. The resultant mixture was cooled to 0° C., and acetyl chloride (171 mg) was added to the mixture, and then the mixture was stirred for 30 minutes. To the resultant reaction mixture, a sodium phosphate buffer having a pH of 7.1 (10 mL) was added, and the resultant mixture was subjected to filtration. The resultant residue was subjected to extraction with chloroform (10 mL×3), and the thus-obtained extract was mixed with the filtrate, and the mixture was separated, thereby obtaining an organic layer. The organic layer was dried over sodium sulfate, and then fractionated and purified through silica gel chromatography, to thereby yield the title compound, 1-[1-acetoxymethyl-2-(hydroxy)ethoxy]methyl-2-nitroimidazole (265 mg).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06743925B1
출처 데이터셋uspto-grants-2004_06
ORD IDord-badfebd506a44a66ba15b0c26f755134
출처 메모uspto-grants-2004_06